Company: XERI
Filing Date: 2025-10-02
Form Type: 10-K
Source: 0001477932-25-007303
Chunk: 310

Company: XERIANT, INC.
Filing Date: 2025-10-02
Form: 10-K
Item: Item 1C
Chunk 310
---
2021, the Certificate of Designation for the Series B Preferred was recorded by the State of Nevada. There are 100,000,000 shares authorized as preferred stock, of which 1,000,000 are designated as Series B Preferred Stock having a par value of $0.00001 per share. The Series B preferred stock is not convertible, grants 5,000 votes and no liquidation preference.

 F-20Table of Contents

Stock Options A summary of the Company’s stock options activity is as follows:   Number of Options   Weighted-Average Exercise Price  Weighted-Average Contractual Term(in years)  Aggregate Intrinsic Value Outstanding at June 30, 2023  21,250,000  $0.12   0.97    Granted  -            Exercised  -   -        Canceled  -   -        Outstanding at June 30, 2024  21,250,000  $0.12   0.13   - Granted  -             Exercised  -   -         Canceled  (21,250,000 )  -         Outstanding at June 30, 2025  -          $- Exercisable at June 30, 2025  -          $-  Significant inputs and results arising from the Black-Scholes process are as follows for the options: Quoted market price on valuation date $0.169 - $0.23 Exercise prices $0.12 Range of expected term 1.55 Years – 2.49 Years Range of market volatility:    Range of equivalent volatility 181.21% - 275.73% Range of interest rates 0.20% - 1.08%  Warrants As of June 30, 2025 and 2024, the Company had 111,568,828 and 118,968,828 warrants outstanding. The warrants have a term of two to five years, and an exercise price range from $0.021 and $0.1187. The Company evaluated the warrants under ASC 815, Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate